Home ECG monitoring to reduce atrial fibrillation episodes
Part of Heart & circulation clinical trials.
This trial uses a home heart monitor (a chest patch with an ECG) to study how atrial fibrillation (an irregular heartbeat) changes over time and how this may help manage symptoms. You may be included if you have a documented, short-lasting type of atrial fibrillation and a moderate amount of AF seen on a 14-day heart recording.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 to 85 years old and have documented paroxysmal atrial fibrillation (episodes usually under 7 days).
- Your recent continuous 14-day heart recording shows AF time between 0.5% and 25%.
- You’ve had AF symptoms in the last 3 months.
- You can use the CardiaCare home monitor (chest patch) and have a smartphone.
- You agree not to change your anti-arrhythmia (rhythm-control) medications during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to deliver energy (FARAPULSE PFA system) to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if these new waveforms can safely and effectively stop AF symptoms and improve quality of life.
This trial tests a new device, the Globe® Pulsed Field System, to treat people with paroxysmal atrial fibrillation (AFib) that comes and goes and causes symptoms, especially if standard medications haven't worked or caused side effects. It's designed to see if this system is a safe and effective option for you.
This study tests a home-monitoring device that tracks irregular heartbeats in patients with a pacemaker. The device sends information to doctors so they can catch and treat problems early.
This study follows patients who have a heart rhythm device (pacemaker, defibrillator, or resynchronization device) and have experienced brief episodes of fast irregular heartbeats detected by the device. The study compares treatment approaches to understand which helps patients stay healthier and feel better.
This trial studies abnormal electrical signals in the right upper heart chamber and how they relate to atrial fibrillation (AF). It may help improve how doctors target AF treatment during catheter ablation for people who have AF symptoms.
This trial tests whether starting treatment early to control your heart's rhythm can help people with a heart device who have short bursts of a fast heartbeat (called atrial high rate episodes) but haven't yet been diagnosed with atrial fibrillation on a standard EKG or Holter monitor.
Hear when a new Paroxysmal Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.